RECENT ADVANCES IN MANAGEMENT OF ANTI-COAGULATION IN ATRIAL FIBRILLATION
Journal: Journal of Heart and Cardiology (Vol.2, No. 1)Publication Date: 2015-09-10
Authors : Puneet Anand;
Page : 1-5
Keywords : Atrial fibrillation; Mechanisms; Management; Therapeutic options;
Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia characterized by uncoordinated electrical activity resulting in increased irregular atrial contraction that ultimately leads to rapid ventricular response. Cardioembolic stroke is one of the major complications of AF and it is responsible for significant embolic events in elderly patients. Cardioembolic stroke accounts for up to 20 % of strokes and the incidence increases with advancing age. Current guidelines recommend anticoagulation for AF with high risk factors for emboli based on CHAD2DS2-Vasc scoring system. Recently, two major classes of non-vitaminK oral anti-coagulants (NOACs) have become available for long-term anti-coagulation in AF: direct thrombin inhibitor (DTI) and factor Xa inhibitor. Here, we discuss the benefits of NOACs over warfarin in specific patient groups with practical guidance on treatment and monitoring strategies. We will highlight the challenges that clinicians face in the modern era of NOACs. We will further discuss the strategies for bleeding prevention and treatment and conclude with discussing future directions in management of AF.
Other Latest Articles
- LECTURES SERIES OF CONGENITAL HEART DISEASE (1) “CYANOTIC CONGENITAL HEART DISEASE
- COMPARISON OF THE EFFECTS OF BARE METAL STENTS AND DRUG ELUTING STENTS ON C- REACTIVE PROTEIN LEVELS
- ECONOMICAL COMPARISION OF AREOTAXI WITH AEROLINES ? SCHEDULED AERO TRANSPORT
- MINIMUM HELIOS ORBITAL MODELING WITH ARDUINO®NANO CHIPS FOR DRIVING SOLAR ENERGY SYSTEM
- DEVELOPMENT AND EVALUATION SOLAR STILL INTEGRATED WITH EVACUATED TUBES
Last modified: 2017-01-06 20:30:45